[1] 胡付品,朱德妹,汪复,等.2018年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2020,20(1):1-10. [2] 田磊,王继军,景红梅,等.恶性血液病患者合并血流感染的临床和病原学特征[J].中国感染与化疗杂志,2017,17(5):504-508. [3] Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing[S].M100-S30.Wayne,PA:CLSI,2007. [4] 王辉,宁永忠,陈宏斌,等.常见细菌药物敏感性试验报告规范中国专家共识[J].中华检验医学杂志,2016,39(1):18-22. [5] WIDMER A F, KERN W V, ROTH J A, et al.Early versus late onset blood stream infection during neutropenia after high?dose chemotherapy for hematologic malignancy[J].Infect,2019,47(5):837-845. [6] 李敏燕,王继红,刘秀婷,等.血液病患者血流感染病原菌分布及耐药性分析[J].创伤与急危重病医学,2017,5(3):157-160. [7] 李元叶,袁欢欢,王盟.某医院重症监护病房住院患者导管相关血流感染病原菌特点及危险因素分析[J].中国消毒学杂志,2020,37(2):34-36,39. [8] OMBELET S, KPOSSOU G, KOTCHARE C, et al.Blood culture surveillance in a secondary care hospital in Benin: epidemiology of bloodstream infection pathogens and antimicrobial resistance[J]. BMC Infectious Diseases,2022,22(1):119. [9] 刘玉. 尿毒症患者临时导管相关性血流感染的危险因素分析[J].江西医药,2020,55(5):597-599. [10] 李敏燕,刘秀婷,刘彦琴,等.急性白血病患者血流感染病原菌分布及耐药性分析[J].临床军医杂志,2018.46(4):395-398. [11] KATOCH O, BAJPAI V, KHURANA S, et al.Clinical epidemiology and risk factors of candida auris bloodstream infection in trauma patients[J].Infect Control Hosp Epidemiol,2020,41(S1):s168. [12] 张艺,郭磊磊,高延秋.真菌血流感染患者病原菌分布及血生化指标水[J].中华医院感染学杂志,2020,30(14):2086-2089. [13] 李平,黄纯.急性白血病患者合并血流感染的病原学、耐药现状及预后高危因素分析[J].中国病原生物学杂志,2021,16(9):1087-1090,1095. [14] 葛鹏,赵海丰.血液系统恶性肿瘤患者侵袭性真菌感染的诊断与治疗进展[J].中国肿瘤临床,2018,45(16):854-858. |